Avita is reinforcing its commitment to reducing health inequities by broadening its impact beyond pharmacy services. Learn more here. …
Year: 2022
340B hospitals use biosimilar drugs less than other hospitals, a PhRMA-funded study found.
340B hospitals use biosimilar drugs less than other hospitals, which may expose patients to higher out-of-pocket costs, a drug industry funded [...] …
AIDS Healthcare Foundation says in a lawsuit that Apexus, the 340B prime vendor, fails and refuses to negotiate sub-ceiling 340B discounts on HIV/AIDS medicines.
AIDS Healthcare Foundation sued Apexus, the federally contracted 340B prime vendor, on Friday for allegedly failing and refusing to negotiate [...] …
An Arkansas health system has asked state insurance officials to enforce the state's 340B contract pharmacy anti-discrimination law against Novo Nordisk.
An Arkansas health system is urging state officials to enforce the state’s novel 340B contract pharmacy anti-discrimination law against drug [...] …
Alas, after much deliberation, your covered entity has decided to submit data to 340B ESP. As you embark on this [...] …
CMS defends its decision to wait until next year to decide how to remedy illegal past cuts in 340B hospitals Part B drug reimbursement.
Federal health officials last week defended their plan to wait until next year to say how they will reimburse 340B [...] …
HRSA has ordered Pennsylvania-based generic drug manufacturer KVK Tech to repay 340B covered entities for program violations found during an audit.
The U.S. Health Resources and Services Administration has ordered Pennsylvania-based generic drug manufacturer KVK Tech to repay 340B covered entities [...] …
The White House yesterday authorized HRSA to publish a proposed rule to replace the 340B administrative dispute resolution final rule HRSA promulgated in late December 2020.
The White House yesterday unexpectedly gave the U.S. Health Resources and Services Administration permission to publish a proposed replacement for [...] …
Today 340B Report takes a closer look at Tuesday's oral arguments in federal circuit court in Philadelphia in three 340B contract pharmacy lawsuits.
Today 340B Report takes a closer look at Tuesday's oral arguments in federal circuit court in Philadelphia in three key [...] …
Gain insights from Omnicell Specialty Pharmacy Services thought leaders and Bausch Health during an informative panel-style discussion …
